Related Experiment Videos
Dicationic diarylfurans as anti-Pneumocystis carinii agents
D W Boykin1, A Kumar, J Spychala
1Department of Chemistry, Georgia State University, Atlanta 30303.
Journal of Medicinal Chemistry
|March 17, 1995
Summary
New dicationic furans show strong DNA binding, inhibiting microbial topoisomerase II. This interaction correlates with effectiveness against Giardia lamblia and Pneumocystis carinii, suggesting a targeted therapeutic model.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Parasitology
Background:
- Dicationic compounds are explored for therapeutic potential.
- DNA-binding agents can target microbial enzymes.
- Giardia lamblia and Pneumocystis carinii are significant pathogens.
Purpose of the Study:
- Synthesize and characterize dicationic 2,5-diarylfurans.
- Evaluate their DNA binding affinities and biological activities.
- Investigate their potential as antimicrobial agents.
Main Methods:
- Synthesis of seven dicationic 2,5-diarylfurans.
- DNA interaction studies using Tm measurements.
- Enzyme inhibition assays for topoisomerase II.
- In vitro and in vivo antimicrobial efficacy testing.
Main Results:
- Strong DNA binding affinities observed for dicationic furans.
- DNA binding strength correlates with biological activity.
- Effective inhibition of Giardia lamblia topoisomerase II and growth.
- Compound 1 shows high efficacy against Pneumocystis carinii.
Conclusions:
- Dicationic furans bind to DNA minor groove, inhibiting microbial topoisomerase II.
- DNA interaction is key to the biological activity of these compounds.
- Promising therapeutic potential for treating parasitic infections.